There are 2789 resources available
755P - A machine learning approach applied to gynaecological ultrasound to predict progression-free survival in ovarian cancer patients
Presenter: Francesca Arezzo
Session: ePoster Display
756P - Efficacy of circulating tumor DNA (ctDNA) analysis in the early detection of ovarian cancer progression
Presenter: Jinho Heo
Session: ePoster Display
757P - Investigation of PARP inhibitor resistance through the analysis of serially collected circulating tumor DNA (ctDNA) in ovarian cancer patients
Presenter: Yoo-Na Kim
Session: ePoster Display
758P - Concordance between multiple HRD assays is substantial in high-grade ovarian cancer
Presenter: Wilko Weichert
Session: ePoster Display
759P - Adding dosing of plasmid encoding p62/SQSTM1 to gemcitabine chemotherapy may provide clinical benefits to patients with platinum-resistant ovarian cancer
Presenter: Sergey Polyakov
Session: ePoster Display
760P - Straightforward molecular tests for predicting response and non-response to platinum-based neoadjuvant therapy in high-grade serous ovarian cancer patients
Presenter: Evgeny Imyanitov
Session: ePoster Display
872P - Association between event-free (EFS) and overall survival (OS) in newly diagnosed patients (pts) with locally advanced (LA) head and neck squamous cell carcinoma (HNSCC) ineligible for surgery
Presenter: Christopher Black
Session: ePoster Display
873P - Early efficacy prediction of nasopharyngeal carcinoma based on 3D-ADC acquired during radiotherapy: A phase II prospective study
Presenter: Mei Feng
Session: ePoster Display
874P - Concurrent chemoradiation with cisplatin alone versus cisplatin and capecitabine in treatment of locally advanced head and neck cancer
Presenter: Abhishek Krishna
Session: ePoster Display
Resources:
Abstract
875P - Definitive chemo-IMRT in locally advanced head and neck squamous cell carcinoma (LAHN-SCC): An experience with geriatric patients
Presenter: Imtiaz Ahmed
Session: ePoster Display